Drug Type Bispecific antibody |
Synonyms ON 09, ON09 |
Target |
Mechanism FOLR1 antagonists(Folate receptor alpha antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Epithelial Carcinoma | Preclinical | AU | 25 May 2024 |